PharmaForceIQ Announces Majority Investment by Eir Partners to Support and Accelerate Growth

PharmaForceIQ Announces Majority Investment by Eir Partners to Support and Accelerate Growth Miami, FL – 10th September 2024, PharmaForceIQ (PFIQ), the leading end to end Omnichannel Solution for Pharmaceutical Marketing, Medical and Clinical teams today announced a significant investment by Eir Partners (Eir) to accelerate adoption of the company’s unique technology platform and services for the Life Science industry.

Verisense Health Introduces an iOS App for its Smart Watch

The Verisense Smart Watch, Which Collects Digital Health Data During Clinical Trials, is Now Compatible with Both Apple and Android Smartphones.

Envision Pharma Group launches EnvisionOne Insights: A unified data and analytics solution for medical affairs

One of the world’s leading technology solutions companies Envision Pharma Group has launched “EnvisionOne Insights” an innovative medical technology solution for the power of big dat

APL and CurifyLabs partnership to support critically ill patients with 3D printing medicine technology

Integrated DNA Technologies Bolsters Comprehensive Genomic Profiling Solutions with Launch of New Archer™ HRD Technology for Cancer Research

Life Sciences Organizations Gain New Real-World Data Offering To Bring Precision Therapies And Diagnostics To Patients

Proscia customers can leverage over 10 million de-identified pathology images alongside corresponding clinical and genomic data

Andrew MacGarvey & Conditor Capital Launch Coronado Research to maximise the use of data and technology in drug development; Dr Nicholas Edwards announced as Chair

Andrew MacGarvey & Conditor Capital Launch Coronado Research to maximise the use of data and technology in drug development; Dr Nicholas Edwards announced as Chair

Global CDMO brings technological advancements & significant capacity to Ocean County, NJ location

FDA Issues Letter of Support for α-Synuclein Seed Amplification Assay – The Core Technology Used in Amprion’s First Commercial Test

Novel assay detects misfolded α-syn in cerebrospinal fluid; A critical drug development tool that can enhance clinical trials and advance life-changing treatments for PD and other neurodegenerative disorders

SPT Labtech and Synthace partner to accelerate drug discovery through accessible DOE

Medical University of Graz Selects the HALO AP® Digital Pathology Platform to Deliver Comprehensive Diagnostics

Indica Labs has announced the Diagnostics & Research Institute for Pathology at the Medical University of Graz has selected the HALO AP® digital pathology platform from Indica Labs to deliver primary diagnostics, alongside Aperio GT 450 scanners from Leica Biosystems.

VedaBio Appoints Dr. G. Brett Robb as Senior Scientific Director and Head of CRISPR Science

VedaBio Appoints Accomplished Leader, Dr. G. Brett Robb, as Senior Scientific Director and Head of CRISPR Science to Drive Platform Expansion and Industrialization

InSysBio to launch Immune Response Template version 3.6.3 for QSP modeling

InSysBio launches Immune Response Template (IRT) version 3.6.3. IRT represents a QSP platform of immune system, simultaneously, being a tool for development of models related to immune system. Veronika Musatova, Head of IRT development team, comments on the new version, “As a result of the update, B cells model reflects the current views on the processes and sequence of this cell type development maintaining a balance between the model detail and complexity.”

Enzene appoints new site Lead for Flagship US continuous bioManufacturing facility

Sapio Sciences Advances The World's First AI-Powered Lab Assistant

Sapio Sciences today announced significant enhancements to Sapio ELaiN, the pioneering AI-powered lab assistant that helps scientists streamline processes and work more efficiently. Sapio ELaiN is also now generally available after a successful beta launch in November 2023.

Phreesia and American Academy of Pediatrics Join in Campaign to Increase Childhood MMR Vaccination

Phreesia and the American Academy of Pediatrics (AAP) have joined forces to increase measles, mumps and rubella (MMR) immunization by reaching parents and caregivers of eligible or soon-to-be eligible children at the point of care. The collaboration comes as immunization rates have dipped in some communities, pointing to a need to improve access to the vaccines that can help keep children healthy.

Indica Labs and Paige Forge Strategic Partnership to Expand Integrated AI for Anatomic Pathology Labs

Indica Labs and Paige have formed a non-exclusive partnership aimed at integrating Paige’s Diagnostic AI models into Indica’s robust Anatomic Pathology workflow management software, HALO AP®.

LabWare Inc. and Mettler-Toledo International Inc. Boost Laboratory Productivity through New Plug-and-Play Software Integration

METTLER TOLEDO is a global leader in precision instruments and services. We are renowned for innovation and quality across laboratory, process analytics, industrial, product inspection, and retailing applications. Our sales and service network is one of the most extensive in the industry. Our products are sold in more than 140 countries, and we have a direct presence in approximately 40 countries. For more information, please visit www.mt.com. LabWare is recognized as the global leader of Laboratory Information Management Systems (LIMS) and instrument integration software products. The company’s Enterprise Laboratory Platform combines the award-winning LabWare LIMS™ and LabWare ELN™, which enables its clients to optimize compliance, improve quality, increase productivity, and reduce costs. LabWare is a full-service informatics provider offering software, professional implementation and validation services, training, and world-class technical support to ensure customers get the maximum value from their LabWare products. Founded in 1987, the company is headquartered in Wilmington, Delaware with offices throughout the world to support customer installations in over 125 countries. For more information, visit the LabWare website at www.labware.com.

PathAI's AISightⓇ Dx Image Management System is CE Marked for Primary Diagnosis

PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, today announced that its AISightⓇ Dx Image Management System (IMS) is In Vitro Diagnostic Regulation (IVDR) certified for use in primary diagnosis. The CE mark paves the way for the company's expansion in the European diagnostic pathology market, enhancing pathologists' interpretations and driving efficiencies and quality improvements within anatomic pathology laboratories.

Alta Stomatology Introduces Scientific Platforms to Advance Oral Disease Drug Development